Physician

George Thomas Zahorian, D.O., F.A.C.O.S.

According to 2025 Medicare claims, George Zahorian, D.O., F.A.C.O.S. (NPI: 1063636033) practices urology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is COCOA UROLOGY ASSOCIATES, P.C. (NPI: 1235389503; TIN: 263403058) and primary practice location at 17033-2217.

Zahorian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 201 traditional Medicare patients, billed 1,989 HCPCS/CPT codes, and received $2,141,075 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 730 prescription claims across 140 beneficiaries totaling $88,101 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 12 claims. Open Payments data shows 8 records totaling $163. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $96,798 to $2,141,075. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $84,764 and ending at $88,101. In contrast, DME billing represents a smaller volume and rose steadily, from $8,407 to $16,512.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	186	1,286	$96,798
2016	210	1,944	$144,638
2017	162	1,798	$128,907
2018	266	1,965	$128,432
2019	264	2,496	$177,257
2020	219	3,906	$421,128
2021	180	4,732	$824,550
2022	226	4,252	$1,343,122
2023	190	1,821	$593,590
2024	201	1,989	$2,141,075

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	115	786	$84,764
2016	145	935	$124,867
2017	148	968	$127,315
2018	182	1,163	$146,226
2019	172	1,101	$111,361
2020	154	1,163	$161,887
2021	150	993	$154,747
2022	139	858	$123,554
2023	151	895	$138,850
2024	140	730	$88,101

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	48	$11,144
2019	N/R	11	$410
2020	N/R	N/R	N/R
2021	N/R	55	$1,330
2022	N/R	93	$5,195
2023	N/R	41	$14,234
2024	N/R	12	$875

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	131	134	$130
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	35	46	$89
11042	Removal of skin and tissue, 20.0 sq cm or less	34	98	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	27	59	$63
81003	Automated urinalysis test	25	49	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	55	2,004	$27,272
Santyl	Collagenase Clostridium Hist.	25	508	$27,084
Silodosin	Silodosin	74	4,748	$6,315
Ketoconazole	Ketoconazole	64	2,713	$3,079
Dutasteride	Dutasteride	67	4,614	$1,943

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7000	Canister, disposable, used with suction pump, each	N	N/R	12	$875

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$163	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George Thomas Zahorian, D.O., F.A.C.O.S.?

Tedicare shows public-source Medicare data for George Thomas Zahorian, D.O., F.A.C.O.S. (NPI 1063636033), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George Thomas Zahorian, D.O., F.A.C.O.S. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George Thomas Zahorian, D.O., F.A.C.O.S.?

George Thomas Zahorian, D.O., F.A.C.O.S. is linked to COCOA UROLOGY ASSOCIATES, P.C. (billing NPI 1235389503) in the available physician profile data.

Does George Thomas Zahorian, D.O., F.A.C.O.S. have Open Payments data?

George Thomas Zahorian, D.O., F.A.C.O.S. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.